Free Trial
LON:AREC

Arecor Therapeutics 4/22/2025 Earnings Report

Arecor Therapeutics logo
GBX 44.78 +1.78 (+4.14%)
As of 12:11 PM Eastern

Arecor Therapeutics EPS Results

Actual EPS
-GBX 0.31
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Arecor Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Arecor Therapeutics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Arecor Therapeutics Earnings Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Arecor Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arecor Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arecor Therapeutics and other key companies, straight to your email.

About Arecor Therapeutics

Arecor Therapeutics (LON:AREC) is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com

View Arecor Therapeutics Profile

More Earnings Resources from MarketBeat